Business
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on May 19, 2026. The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/. About Lexicon Pharmaceuticals L
About this update from Lexicon Pharmaceuticals, Inc.
[{"type":"image","alt":"Lexicon Pharmaceuticals, Inc.","displaySize":"","headline":null,"caption":"Lexicon Pharmaceuticals, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":166,"height":50,"url":"https://media.zenfs.com/en/globenewswire.com/4d6e4fe42ab02751f185e7d242d7f8e8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cpcXdPITJqolET8.Vg1gcg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTYz/https://media.zenfs.com/en/globenewswire.com/4d6e4fe42ab02751f185e7d242d7f8e8","width":166,"height":50},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/cpcXdPITJqolET8.Vg1gcg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTYz/https://media.zenfs.com/en/globenewswire.com/4d6e4fe42ab02751f185e7d242d7f8e8","width":166,"height":50}},"lazy":false},{"type":"text","content":"THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on May 19, 2026.","length":327,"tagName":"p"},{"type":"text","content":"The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.","length":150,"tagName":"p"},{"type":"text","content":"About Lexicon Pharmaceuticals Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.","length":464,"tagName":"p"},{"type":"text","content":"For Media Inquiries:Dave BelianLexicon Pharmaceuticals, [email protected]","length":86,"tagName":"p"},{"type":"text","content":"For Investor Inquiries:Lisa DeFrancescoLexicon Pharmaceuticals, [email protected]","length":94,"tagName":"p"},{"type":"text","content":"","length":0,"tagName":"p"}]